1. |
PM10 and PM2.5
|
Zhejiang and Shanxi, China |
2012–2014 |
120 participants |
Increased mtDNA copy number and IL-5 concentration |
Wang et al. (2020a) |
2. |
PM10 and PM2.5
|
Italy |
2014–2015 |
50 healthy adult volunteers |
Impaired the immune system |
Dolci et al. (2018) |
3. |
PM10 and PM2.5
|
Jinan, Shandong |
2016 |
163 and 110 school children from the polluted and control areas, respectively |
Decreased C3 and C4 levels, and B lymphocyte count |
Li et al. (2019b) |
4. |
PM10
|
South Korea |
2012–2013 |
100 participants |
Impacts DNA methylation and immune responses |
Lee et al. (2019) |
5. |
PM2.5
|
Mexico City |
2013–2017 |
35 residents |
Alters functional immune cell responses and increased risk for Tuberculosis development |
Torres et al. (2019) |
6. |
PM2.5
|
Japan |
2014–2015 |
Cell line study |
Activated antigen presenting cells and T-cells led to respiratory diseases |
Chowdhury et al. (2018) |
7. |
PM2.5
|
Shanghai, China |
2016 |
43 volunteers |
Saliva lysozyme (non-specific immune biomarker) was significantly inversely associated with indoor PM2.5
|
Gao et al. (2019a, b)
|
8. |
PM2.5
|
United States |
2012–2013 |
21 volunteers |
Impairs critical antimycobacterial T cell immune functions |
Ibironke et al. (2019) |
9. |
PM2.5
|
United States |
2003–2011 |
774 participants |
Impacts DNA methylation and the human immune system |
Gao et al. (2019a, b)
|
10 |
PM2.5
|
252 Chinese cities |
2013–2017 |
117,338,867 hospital admissions |
Increased risk of diseases in the digestive, musculoskeletal, and genitourinary systems |
Gu et al. (2020) |